H.R. 124 · 118th Congress

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Stage
In committee
Sponsor
Al Green
Introduced
2023-01-09
Latest action
2023-01-20 · Referred to the Subcommittee on Health.

Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)